Created Sep 24, 2026 · Latest reported quarter, ended Jun 30, 2026 (Q2): MFC, SLF, IFC, FFH
MFC SLF IFC FFH — still Financials, but a genuinely different sub-industry from the banks in Module 0001. Two life & wealth insurers (Manulife, Sun Life) and two property & casualty insurers (Intact, Fairfax), grouped together because they're the sector's next-largest block after the banks, not because they run the same business. The KPI split below is the first lesson of this module: life and P&C insurance aren't comparable on the same metrics, and knowing which metric belongs to which business is itself part of the fluency.
| Company | Distinguishing characteristic |
|---|---|
| MFC Manulife | Life insurance and wealth/asset management across Asia, Canada, and the US (under the John Hancock brand), plus Global Wealth & Asset Management (Manulife Investment Management). Asia is the primary long-term growth engine. Since 2023 has reinsured a series of legacy, low-ROE US blocks — including $6B of long-term-care reserves to Global Atlantic and a further $2.4B LTC block to RGA — freeing capital to redeploy toward Asia and wealth/asset management. |
| SLF Sun Life | Similarly diversified across insurance, wealth, and US group benefits — but distinguished by MFS Investment Management, a majority-owned, Boston-based active asset manager that's been part of Sun Life since 1982 and gives it a more established, freestanding capital-light fee business than Manulife's asset-management arm. Also runs a US dental-benefits business (DentaQuest), currently under restructuring. Less Asia-weighted than Manulife, though Asia is a stated growth priority. |
| IFC Intact Financial | Canada's largest property & casualty insurer (personal auto, home, and commercial lines), and owner of BrokerLink, the country's largest P&C broker network. Materially expanded internationally via the 2021 acquisition of RSA Insurance Group's UK, Canada and International businesses (co-acquired with Denmark's Tryg), creating a standalone UK & International segment and a stated goal of doubling that business by 2030. |
| FFH Fairfax Financial | A globally diversified P&C insurance and reinsurance holding company run through dozens of largely autonomous underwriting subsidiaries (Odyssey Re, Allied World, Brit, Zenith National, Crum & Forster, Northbridge, and more). The real distinguishing feature: Fairfax is run as much as an actively managed investment company as an insurer — Chairman/CEO Prem Watsa and team drive a concentrated, value-oriented investment portfolio on top of the insurance float, rather than a passively duration-matched bond book like most peers. |
Definitions for every metric below live in the Sector KPI Glossary — Insurance. Read that first if any term feels rusty; it won't be re-explained here.
Trailing (reported, not consensus) price/earnings multiple, quarter-end, Q3 2021 through Q3 2026 (21 quarters). Hover any quarter for exact values; MFC's Q3 2022–Q1 2023 stretch is excluded as not economically meaningful (see note below the chart).
Source: stockanalysis.com quarterly ratio history (fetched Sep 24, 2026), trailing-12-month EPS basis — not a consensus/forward multiple; free sources don't carry a historical forward-P/E time series, only a current-point forward estimate. MFC, Q3 2022–Q1 2023, is excluded (shown as a gap): quarterly net income swung to near-zero or negative in that stretch — largely equity-market and actuarial-assumption volatility hitting segregated-fund/LTC reserves ahead of the 2023 IFRS 17 transition — which makes a P/E multiple mathematically explosive (readings like -41x and 95x) rather than economically meaningful. FFH, Q2 2022, is excluded for the same reason (single quarter). Treat every value as a snapshot subject to restatement, not a smoothed series.
| Metric (Q2 2026) | MFC | SLF |
|---|---|---|
| Core / underlying ROE | 16.3% | 19.1% |
| Reported ROE | 18.0% | 17.2% |
| LICAT ratio | 136% | 145% |
| Core/underlying earnings growth (YoY) | +12% | +10% |
| Core/underlying EPS growth (YoY) | +16% | +13% |
Manulife: core earnings C$1,923M, APE sales +21% YoY, new business CSM +16%, new business value +10% YoY. Sun Life: underlying net income C$1.12B, organic capital generation 41%; growth was uneven — Canada, US and Asia posted double-digit growth, but MFS saw continued net outflows and DentaQuest remained under restructuring pressure.
| Metric (Q2 2026) | IFC | FFH |
|---|---|---|
| Combined ratio (Q2 2026) | 94.9%† | 93.1% undiscounted / 81.9% IFRS 17† |
| Segment color | Personal auto 88.8%, Commercial 85.7%; Personal property hit by elevated cat losses | Underwriting profit $458.6M |
| ROE (reported / adjusted) | 17.2% / 19.3% | not headlined quarterly — judged on BVPS growth instead |
| Book value per share growth (Q2 2026, dividend-adjusted) | — | +4.8% |
| Net earnings (Q2 2026) | — | $1,392.7M ($63.38/diluted share) |
† See combined-ratio comparability caveat below before reading the 94.9% vs 81.9% gap as a performance difference.
Market data below is a single-source snapshot (stockanalysis.com, Sep 24, 2026) so the four are at least internally consistent; the dividend-policy descriptions are separately sourced and dated where noted.
| Metric | MFC | SLF | IFC | FFH |
|---|---|---|---|---|
| Dividend yield (Sep 24, 2026) | 3.15% | 3.42% | 2.35% | 0.93% |
| P/E (TTM) (Sep 24, 2026) | 16.65x | 19.08x | 13.94x | 7.67x |
| Market cap (CAD, approx.) (Sep 24, 2026) | ~$102B | ~$63B | ~$44B | ~$44B |
| Dividend policy | Progressive; raised 10.2% to $0.485/qtr in Mar 2026 | Progressive; raised 4.5% to $0.92/qtr in Dec 2025 | 21st consecutive annual increase, +$0.14/share, Mar 2026 | Single annual dividend ($15/share, paid Q1 2026) rather than a growing quarterly one |
Approximate total return, five-year window ending ~Sep 2026, gathered from public trackers (financecharts.com, portfolio/return summaries cross-referenced via search). Flagged explicitly as approximate — see the caveat below before quoting any of these to a decimal point.
Total return (dividend-adjusted close), weekly, five years, all four names indexed to 100 at the first week (Sep 20, 2021). Hover anywhere on the chart for exact values on that week.
Source: Yahoo Finance weekly dividend-adjusted close (fetched Sep 25, 2026), Sep 20, 2021–Sep 24, 2026, TSX-listed (CAD). This is a genuine total-return series (dividends reinvested via Yahoo's adjusted-close methodology), not a price-only proxy. These figures will differ from the annual 5-year-return table above (which cited a different tracker/date range) — the ranking (FFH > MFC > SLF > IFC) matches, but magnitudes vary by source, exactly the caveat already flagged. Treat any single total-return figure as source- and date-dependent, never as one clean number.
| Rank | Company | 5-Yr Total Return (approx.) |
|---|---|---|
| 1 | FFH Fairfax Financial | ~+338% |
| 2 | MFC Manulife | ~+179% |
| 3 | SLF Sun Life | ~+98% |
| 4 | IFC Intact Financial | ~+78% |
The single largest idiosyncratic driver of this group's return spread, and a good test case for reasoning about an accounting challenge without either dismissing it or treating it as settled.
Through 2020–2021's near-zero-rate environment, Fairfax deliberately kept its roughly $38 billion fixed income portfolio very short — about half in cash and T-bills at the end of 2021 — on the explicit view that locking in near-zero yields for decades wasn't worth it. That positioning paid off directly in 2022's historic bond bear market: with average duration of just 1.6 years by year-end, Fairfax's fixed income book fell only about 2.9%, while longer-duration peers absorbed far larger mark-to-market losses.
As rates rose through 2022 and into 2023, Watsa and team reversed course — extending duration and buying Treasuries to lock in the now-higher yields, a shift Watsa confirmed directly at Fairfax's April 2023 annual meeting. The payoff was structural, not a one-quarter blip: interest and dividend income roughly tripled, from a run rate of about $530 million/year at the end of 2021 to about $1.5 billion/year by 2022–23 — income that a held-to-maturity bond book keeps generating for years, not a single lucky quarter.
On February 27, 2024, short-seller Muddy Waters Research published a roughly 72-page report alleging Fairfax had overstated its book value by approximately US$4.5 billion through the accounting treatment of 13 specific investments, subsidiaries and joint ventures. The stock fell as much as ~13% intraday on the report. Fairfax's response was immediate and comprehensive: it categorically denied every allegation as "false and misleading," noted that Muddy Waters never contacted the company before publishing, criticized the timing (during Fairfax's quiet period), and issued detailed line-by-line rebuttals of the specific claims.
Distinct from the bank module in one important way: a P&C insurer's underwriting cycle ("hard market" vs. "soft market") runs on its own clock, largely independent of the interest-rate cycle that dominates how life insurers and bond portfolios respond.
New money yields rise, directly lifting investment income on the float for all four — most visible in Fairfax's case, per the deep dive above — but existing fixed-rate bond holdings take mark-to-market losses in the interim (how much hits reported earnings vs. equity depends on IFRS 9 classification). For the life insurers (MFC, SLF), rising rates generally reduce the present value of long-dated insurance liabilities, which tends to help capital ratios like LICAT, though guarantees embedded in older segregated-fund and annuity blocks can cut either way depending on the specific guarantee structure.
The mirror image: new money yields fall, the existing bond book gains in value, and long-dated insurance liability values rise — a headwind for life-insurer capital ratios that a strong underlying business can still offset.
Distinct from the rate cycle — driven by industry-wide claims-cost inflation, reinsurance capacity and pricing, and recent catastrophe loss experience. A "hard market" (premium rates rising, terms tightening, typically following a run of large industry losses) benefits IFC and FFH's underwriting margins directly; a "soft market" (excess capacity chasing premium growth, pricing competition) compresses combined ratios industry-wide, independent of what rates are doing.
Both P&C names carry real, recurring exposure to weather catastrophe losses (wildfire, flood, severe convective storm, and for Fairfax's global book, hurricane) — a structural and, on current trend, worsening cost line rather than a one-off. Claims-cost inflation (auto parts and labor, construction materials) pressures loss ratios industry-wide too, on a different track from the CPI figure a client reads about.
For MFC and SLF, a sharp equity-market decline hits segregated-fund and wealth AUM-based fee income directly, and can trigger reserve strengthening on older variable-annuity/segregated-fund guarantee blocks — part of why both companies have been actively reinsuring those blocks away (see Manulife's business-model note above). Fairfax is the outlier here too: its investment portfolio has historically carried meaningful equity and equity-hedge positions, making its results more sensitive to equity-market moves than the other three's more fixed-income-weighted portfolios.
SLF's MFS gives it a more established, freestanding capital-light fee-income stream than Manulife's asset-management arm carries at comparable brand recognition — though MFS's current net-outflow trend is exactly the kind of near-term execution risk that framework should weigh against the structural appeal of a fee-based business.
FFH (7.67x) and MFC (16.65x) both still carry cheaper multiples than SLF (19.08x), leaving more re-rating room if execution continues; IFC and SLF's higher multiples already price in their reputations for consistency.
IFC's 21-year dividend-growth streak and FFH's retain-and-compound approach are genuinely different ways to return value to shareholders — worth matching to what a specific client actually wants (income vs. total-return compounding) rather than treating one as objectively superior to the other.
IFC's UK & International expansion, FFH's globally decentralized subsidiary structure, and MFC/SLF's Asia and US exposure are each a different diversification path, carrying a different currency and regulatory-regime risk profile — worth naming the specific exposure rather than treating "international diversification" as one uniform positive.
Thirteen new questions covering business model, the life/P&C KPI split, dividends, five-year returns, and the Fairfax deep dive, plus two review questions from Module 0001 (Big Six Banks) interleaved in, per the due-for-review list in PROGRESS.md.